Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Murray, Kathryn; Wilkinson-Smith, Victoria; Hoad, Caroline; Costigan, Carolyn; Cox, Eleanor; Lam, Ching; Marciani, Luca; Gowland, Penny; Spiller, Robin C (2013)
Publisher: Nature Publishing Group
Journal: The American Journal of Gastroenterology
Languages: English
Types: Article
Subjects: Colon/Small Bowel
OBJECTIVES: The objective of this study was to investigate whether ingestion of fructose and fructans (such as inulin) can exacerbate irritable bowel syndrome (IBS) symptoms. The aim was to better understand the origin of these symptoms by magnetic resonance imaging (MRI) of the gut. METHODS: A total of 16 healthy volunteers participated in a four-way, randomized, single-blind, crossover study in which they consumed 500 ml of water containing 40 g of either glucose, fructose, inulin, or a 1:1 mixture of 40 g glucose and 40 g fructose. MRI scans were performed hourly for 5 h, assessing the volume of gastric contents, small bowel water content (SBWC), and colonic gas. Breath hydrogen (H 2) was measured and symptoms recorded after each scan. RESULTS: Data are reported as mean (s.d.) (95 % CI) when normally distributed and median (range) when not. Fructose increased area under the curve (AUC) from 0 – 5 h of SBWC to 71 (23) l / min, significantly greater than for glucose at 36 (11 – 132) l / min ( P < 0.001), whereas AUC SBWC after inulin, 33 (17 – 106) l / min, was no different from that after glucose. Adding glucose to fructose decreased AUC SBWC to 55 (28) l / min ( P = 0.08) vs. fructose. Inulin substantially increased AUC colonic gas to 33 (20) l / min, signifi cantly greater than glucose and glucose + fructose (both P < 0.05). Breath H 2 rose more with inulin than with fructose. Glucose when combined with fructose signifi cantly reduced breath H 2 by 7,700 (3,121 – 12,300) p.p.m. / min relative to fructose alone ( P < 0.01, n = 13). CONCLUSIONS: Fructose but not inulin distends the small bowel with water. Adding glucose to fructose reduces the effect of fructose on SBWC and breath hydrogen. Inulin distends the colon with gas more than fructose, but causes few symptoms in healthy volunteers.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Francis CY, Whorwell PJ. Bran and irritable-bowel-syndrome - time for reappraisal. Lancet 1994;344:39-40.
    • 2. Nanda R, James R, Smith H et al. Food intolerance and the irritable bowel syndrome. Gut 1989;30:1099-104.
    • 3. Parker TJ, Naylor SJ, Riordan AM et al. Management of patients with food intolerance in irritable bowel syndrome - the development and use of an exclusion diet. J Hum Nutr Diet 1995;8:159-66.
    • 4. Staudacher HM, Whelan K, Irving PM et al. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet 2011;24:487-95.
    • 5. Staudacher HM, Lomer MCE, Anderson JL et al. Fermentable carbohydrate restriction reduces luminal bifi dobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012;142:1510-8.
    • 6. Shepherd SJ, Parker FC, Muir JG et al. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008;6:765-71.
    • 7. Shepherd SJ, Nut M, Gibson PR. Fructose malabsorption and symptoms of irritable bowel syndrome: guidelines for ef ective dietary management. J Am Diet Assoc 2006;106:1631-9.
    • 8. de Roest RH, Dobbs BR, Chapman BA et al. Th e low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract 2013;67:895-905.
    • 9. Shepherd SJ, Lomer MCE, Gibson PR. Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol 2013;108:707-17.
    • 10. Ong DK, Mitchell SB, Barrett JS et al. Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010;25:1366-73.
    • 11. Barrett JS, Gearry RB, Muir JG et al. Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon. Aliment Pharmacol Th er 2010;31:874-82.
    • 12. Rumessen JJ, Gudmand-Hoyer E. Fructans of chicory: intestinal transport and fermentation of dif erent chain lengths and relation to fructose and sorbitol malabsorption. Am J Clin Nutr 1998;68:357-64.
    • 13. Marciani L, Cox EF, Hoad CL et al. Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome. Gastroenterology 2010;138:469-U90.
    • 14. Rumessen JJ, Gudmandhoyer E. Absorption capacity of fructose in healthy adults-comparison with sucrose and its constituent monosaccharides. Gut 1986;27:1161-8.
    • 15. Truswell AS, Seach JM, Th orburn AW. Incomplete absorption of pure fructose in healthy subjects and the facilitating ef ect of glucose. Am J Clin Nutr 1988;48:1424-30.
    • 16. Parker K, Salas M, Nwosu VC. High fructose corn syrup: production, uses and public health concerns. Biotechnol Mol Biol Rev 2010;5:71-8.
    • 17. Christopher NL, Bayless TM. Role of the small bowel and colon in lactoseinduced diarrhea. Gastroenterology 1971;60:845-52.
    • 18. Placidi E, Marciani L, Hoad CL et al. Th e ef ects of loperamide, or loperamide plus simethicone, on the distribution of gut water as assessed by MRI in a mannitol model of secretory diarrhoea. Aliment Pharmacol Th er 2012;36:64-73.
    • 19. van den Bogert B, de Vos WM, Zoetendal EG et al. Microarray analysis and barcoded pyrosequencing provide consistent microbial profi les depending on the source of human intestinal samples. Appl Environ Microbiol 2011;77:2071-80.
    • 20. Hoad CL, Marciani L, Foley S et al. Non-invasive quantifi cation of small bowel water content by MRI: a validation study. Phys Med Biol 2007;52:6909-22.
    • 21. Jones HF, Butler RN, Brooks DA. Intestinal fructose transport and malabsorption in humans. Am J Physiol Gastrointest Liver Physiol 2011;300:G202-6.
    • 22. Gouyon F, Caillaud L, Carriere V et al. Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice. J Physiol London 2003;552:823-32.
    • 23. Rumessen JJ, Bode S, Hamberg O et al. Fructans of Jerusalem artichokes - intestinal transport, absorption, fermentation and infl uence on blood glucose, insulin and c-peptide responses in healthy subjects. Am J Clin Nutr 1990;52:675-81.
    • 24. Cherbut C. Inulin and oligofructose in the dietary fi bre concept. Br J Nutr 2002;87:S159-62.
    • 25. Bond JH, Levitt MD. Investigation of small bowel transit-time in man utilizing pulmonary hydrogen (H2) measurements. J Lab Clin Med 1975;85:546-55.
    • 26. Roberfroid MB. Caloric value of inulin and oligofructose. J Nutr 1999;129:1436S-7S.
    • 27. Spiller RC, Jones BJM, Silk DBA. Jejunal water and electrolyte absorption from 2 proprietary enteral feeds in man-importance of sodium content. Gut 1987;28:681-7.
    • 28. Douard V, Ferraris RP. Regulation of the fructose transporter GLUT5 in health and disease. Am J Physiol Endocrinol Metabol 2008;295: E227-37.
    • 29. Wasserman D, Hoekstra JH, Tolia V et al. Molecular analysis of the fructose transporter gene (GLUT5) in isolated fructose malabsorption. J Clin Invest 1996;98:2398-402.
    • 30. Roberfroid MB. Inulin-type fructans: functional food ingredients. J Nutr 2007;137:2493S-502S.
    • 31. Koide A, Yamaguchi T, Odaka T et al. Quantitative analysis of bowel gas using plain abdominal radiograph in patients with irritable bowel syndrome. Am J Gastroenterol 2000;95:1735-41.
    • 32. Morken MH, Berstad AE, Nysaeter G et al. Intestinal gas in plain abdominal radiographs does not correlate with symptoms aft er lactulose challenge. Eur J Gastroenterol Hepatol 2007;19:589-93.
    • 33. Youn YH, Park JS, Jahng JH et al. Relationships among the lactulose breath test, intestinal gas volume, and gastrointestinal symptoms in patients with irritable bowel syndrome. Dig Dis Sci 2011;56:2059-66.
    • 34. Harder H, Serra J, Azpiroz F et al. Intestinal gas distribution determines abdominal symptoms. Gut 2003;52:1708-13.
    • 35. Spiller R. New insights into bloating and abdominal distension: is it all outlet obstruction? Am J Gastroenterol 2010;105:888-9. hT is work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.
    • org/licenses/by-nc-sa/3.0/
  • No related research data.
  • Discovered through pilot similarity algorithms. Send us your feedback.

Share - Bookmark

Cite this article